In This Article:
Justera is a Canadian company focused on health and wellness, offering personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements, and a full 360-degree wellness and spa experience. (Source: 'Justera is a Canadian company focused on health and wellness...')
The acceleration clause will come into effect if the Company's shares trade on the CSE at or above $0.10 per share for a period of 5 consecutive trading days. (Source: 'should the Company's shares trade on the CSE at or above $0.10 per share for a period of 5 consecutive trading days, a forced exercise provision will come into effect.')
Investors can find more information about Justera Health Ltd. on the Company's website at https://www.justerahealth.com/ and on the Company's profile on SEDAR+ at www.sedarplus.com. (Source: 'For additional information on Justera Health and other corporate information, please visit the Company's website...')
Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share for an additional Common share of the Company, for a period of 5 years. (Source: 'Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share...')
The purpose of the shares for debt settlement transactions is to settle an aggregate of $355,570 owed to a non-arm's-length creditor of the Company by issuing 7,111,400 Units at a deemed price of C$0.05 per Unit. (Source: 'An aggregate of $355,570 owed to non-arm's-length creditor of the Company... has been settled by issuing 7,111,400 Units...')
TORONTO, ON / ACCESSWIRE / October 21, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce that it has closed previously announced shares for debt settlement transactions (see press release dated October 4, 2024). An aggregate of $355,570 owed to non-arm's-length creditor of the Company (the "Creditor") has been settled by issuing 7,111,400 Units (the " Units ") at a deemed price of C$0.05 per Unit. Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share for an additional Common share of the Company, for a period of 5 years (the " Debt Transaction "). The warrants will be subject to an acceleration clause whereby should the Company's shares trade on the CSE at or above $0.10 per share for a period of 5 consecutive trading days, a forced exercise provision will come into effect. The Common Shares and the Warrants to be issued pursuant to the Debt Transaction will be subject to a hold period of four (4) months and one (1) day from the date of issuance.
About Justera Health
Established in 2020, Justera is a Canadian company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.
For additional information on Justera Health and other corporate information, please visit the Company's website at https://www.justerahealth.com/
For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.com.
For further information:
Investor Relations & Communications
Paul Haber, CFO
Tel: (416) 318-6501
Email: [email protected]
Forward-Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions.All statements included herein, other than statements of historical fact, are forward-looking ?statements, including but not limited to: the terms, timing and completion of the Transaction, if the Transaction is to close at all, the receipt of all necessary regulatory and CSE approvals, authorizations and consents in connection with the Transaction, and the completion or waiver, as applicable, of all conditions precedent required for the completion of the Transaction; the anticipated business plans, management structure, and future activities of the Company and Port North, including the Company's intention to integrate Port North into its business; and the anticipated benefits and synergies to be derived from the Transaction on the business of both Port North and the Company; and the date in which the Payment Shares may become free-trading.